Advertisement

Topics

Latest "Airlines Reporting Corporation" News Stories

23:50 EST 17th November 2018 | BioPortfolio

Here are the most relevant search results for "Airlines Reporting Corporation" found in our extensive news archives from over 250 global news sources.

More Information about Airlines Reporting Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Airlines Reporting Corporation for you to read. Along with our medical data and news we also list Airlines Reporting Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Airlines Reporting Corporation Companies for you to search.

Showing "Airlines Reporting Corporation" News Articles 1–25 of 1,800+

Saturday 17th November 2018

MultiVendor Support Services Market by Service Type Hardware and Software Support Services, Business Application Sales and Marketing, Financial and Accounting, Supply Chain, and IT Operations, Vertical, and Region Global Forecast to 2023 [Report Updated:

The MultiVendor Support Services MVSS market is expected to grow at a Compound Annual Growth Rate CAGR of 2.52% during the forecast periodThe global MVSS market size is expected to grow from USD 53.09 billion in 2018 to USD 60.14 billion by 2023, at a Compound Annual Growth Rate CAGR of 2.52% during the forecast period. Major growth factors for the market include the rapidly increasing changes in ...


Friday 16th November 2018

FDA approves Novartis drug Promacta® for first-line SAA and grants Breakthrough Therapy designation for additional new indication

Novartis International AG / FDA approves Novartis drug Promacta® for first-line SAA and grants Breakthrough Therapy designation for additional new indication . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Promacta receives FDA approval for first-line treatment of severe aplastic anemia (SAA) and Breakthro...

New Findings Presented at the VEITHsymposium Reiterate Consistent, Durable Outcomes in Complex Aortic Disease with Heli-FX(TM) Endoanchor(TM) System

Three-Year Data from the ANCHOR Registry Reiterate Applicability in Patients with Hostile Aortic Neck Anatomies DUBLIN and NEW YORK - November 16, 2018 - Medtronic plc (NYSE:MDT) today announced new data on the Heli-FX(TM) EndoAnchor(TM) system, which demonstrated durability, safety and efficacy in patients with complex aortic abdominal aneurysm (AAA) anatomy, particularly those ...


Novartis receives positive CHMP opinion to expand Kisqali® combination therapy to all women with HR+/HER2- locally advanced or metastatic breast cancer

Novartis International AG / Novartis receives positive CHMP opinion to expand Kisqali® combination therapy to all women with HR+/HER2- locally advanced or metastatic breast cancer . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Kisqali is the CDK4/6 inhibitor with the ...

Cardinal Health, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 15102018] Prices from USD $175

Cardinal Health, Inc. Strategy, SWOT and Corporate Finance ReportSummaryCardinal Health, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsCardinal Health, Inc. Cardin...

Sanofi: European Medicines Agency recommends fexinidazole, the first all-oral treatment for sleeping sickness

European Medicines Agency recommends fexinidazole, the first all-oral treatment for sleeping sickness The positive opinion is the result of a 10-year partnership between the Drugs for Neglected Diseases initiative (DNDi), Sanofi and African partners Fexinidazole will support international efforts to eliminate sleeping sickness, a

MedMen Appoints Jim Miller as Interim CFO

MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) (FSE: A2JM6N) announced today that Chief Financial Officer James Parker resigned, and that Jim Miller, the Company’s vice president of accounting, has been appointed interim chief financial officer until Parker’s successor is named. Miller joined MedM...

E-9 Corporation Awarded Contract to Deliver Emergency Reporting Fire RMS and ePCR Solution for the U.S. Army

SPRINGFIELD, Va. (PRWEB) November 16, 2018 E-9 Corporation (E-9) is a leader providing the DoD with Risk Management Framework (RMF) approved, cloud-based Force Protection and Emergency Management solutions who announced today that, in collaboration with Emergency Reporting (ER), they have bee...

LIDDS participates at Redeye Life Science Day

The Life Science Event takes place at Haymarket by Scandic on November 21. CEO Monica Wallter will present the company and update the audience on the latest developments of the NanoZolid technology platform. The LIDDS presentation goes live at 10.20 and can be followed on the following link: www.redeye.se/live/lsday-2018The video can also be viewed later at www.redeye.se/live/ls-day-2018 or...

LIDDS presence at BIO-Europe 2018 to focus on NanoZolid's broad drug formulation capability

The Life Science Event takes place at Haymarket by Scandic on November 21. CEO Monica Wallter will present the company and update the audience on the latest developments of the NanoZolid technology platform. The LIDDS presentation goes live at 10.20 and can be followed on the following link: www.redeye.se/live/lsday-2018The video can also be viewed later at www.redeye.se/live/ls-day-2018 ...

Immunicum AB (publ) Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Ilixadencel in Combination with Avelumab in Multi-Indication Phase Ib/II Study

Press Release 16 November 2018 Immunicum AB (publ) Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Ilixadencel in Combination with Avelumab in Multi-Indication Phase Ib/II Study Immunicum AB (publ; IMMU.ST) announced today that it has entered into a collaboration agreement with Merck KGaA, Darmstadt, Germany, and Pfizer to evaluate its lead ...

Biofrontera AG: Biofrontera reports earnings results for the third quarter and first nine months of 2018

DGAP-News: Biofrontera AG / Key word(s): 9-month figures 16.11.2018 / 08:05 The issuer is solely responsible for the content of this announcement. Biofrontera reports earnings results for the third quarter and first nine months of 2018 Leverkusen, Germany, November 16, 2018 - Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the "Company"), an international biopharmaceutica...

Xbrane Biopharma releases interim report for the third quarter of 2018

Press release2018-11-16   Xbrane Biopharma AB's (publ.) ("Xbrane") interim report for the third quarter of 2018 is now available on the Company's website, www.xbrane.com. Financial summary third quarter 2018 Revenue amounted to SEK 2,441 thousand (-). Gross margin amounted to 21% (-). Other operating income amounted to SEK 84,041 thousand (331), of w

DBV Technologies Appoints Daniel Tassé as Chief Executive Officer

Montrouge, France, November 16, 2018 DBV Technologies Appoints Daniel Tassé as Chief Executive Officer Daniel brings strong track record of building and leading global organizations and delivering transformative products to patients Co-founder Dr. Pierre-Henri Benhamou to retire as CEO and serve as Non-Executive Chairman of the Board DBV Technologies ...

Thursday 15th November 2018

Lancaster University supports global initiative to calculate 'value' of employees

(Lancaster University) A report from the Embankment Project for Inclusive Capitalism (EPIC) is launched today offering a new framework for reporting the contribution employees make to an organisation. EPIC was set up to make corporate reporting more useful and involves companies like Nestle, Unilever, PepsiCo and Johnson & Johnson that represent $30 trillion of assets under management and almost 2...

ERYTECH Partners with New York Blood Center for Red Blood Cell Supply and Research

LYON, France and CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, today announced a strategic partnership with New York Blood Center (NYBC) for red blood cell supply and research. The partnership encompasses N...

SPINEWAY :Spineway sets up the governing structure for its US subsidiary

Press release                                                                                                                                                                 Ecully, 15 November 2018 Spineway sets up the gove...

Vets First Choice Adds Chief Financial Officer and Chief Human Resources Officer in Advance of Merger with Henry Schein Animal Health

Christine Komola and Jim Young Join Vets First Choice as CFO and CHRO Vets First Choice, a leading provider of technology-enabled health care services for companion and equine veterinary practitioners, today announced the recent appointment of Christine Komola as Executive Vice President and Chief Financial Officer and Jim Young as Senior Vice Pre...

Premier Inc. Survey: Nearly 75% of Health Systems Report Interest in Value-Based Contracting

Although gaining ground, limited engagement from suppliers and data challenges are the main barriers to more widespread adoption of value-based contracts in the supply chain Although 73 percent of healthcare providers rank value-based contracting with suppliers as a priority for improving return on investments, opportunities lag in the healthcare suppl...

VirtualHealth Ranked 39th Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500™

Attributes 3336 percent revenue growth to the rapid adoption of its leading care management platform across the healthcare industry VirtualHealth, the leading SaaS platform for care management and population health, today announced it ranked No. 39 on Deloi

Artificial Intelligence Key to Improving Health Care Quality, Reducing Costs, Industry Leaders Say

OptumIQ survey of health care executives finds majority (91 percent) confident they will see an ROI on AI – although not immediately First wave of AI implementation focused on improving processes; combating waste, fraud and abuse; and maximizing impact of IoT, such as wearable devices Investing in the...

Hengrui Pharma Partners with Medidata to Accelerate Global Drug Research

Leading Sponsor in China to Deliver Innovative Therapies to Patients Worldwide with Medidata Cloud News summary: Hengrui adds Medidata Rave EDC, RTSM, Coder, Safety Gateway and Edge CTMS to support emerging market strategy Medidata Cloud enables unified data management for global clinical trial expansion...

Quick Take: Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study

In the evaluation of thyroid nodules, fine needle aspirate (FNA) cytology can classify most thyroid nodules as benign or malignant; a minority of results, however, remain indeterminate. The Bethesda System for Reporting Thyroid Cytopathology includes 3 categories for indeterminate cytology (categories III, IV and V). Most indeterminate nodules are either sampled again or prophylactically removed. ...

Aradigm Announces Third Quarter 2018 Financial Results

Aradigm Corporation (NASDAQ: ARDM) (the "Company") today announced financial results for the third quarter and nine months ended September 30, 2018. Third Quarter 2018 Financial Results The Company recorded $282,000 in revenue in the third quarter of 2018 compared with $2.7 million in revenue in the third quarter of 2017. The ...

Schrödinger Names Veteran Pharma Executive Joel Lebowitz as Chief Financial Officer

Schrödinger, a privately held company revolutionizing drug discovery and materials design through advanced molecular simulations, today announced the appointment of veteran pharmaceutical executive Joel Lebowitz as chief financial officer. Mr. Lebowitz, a longtime senior executive at Merck, brings to the company deep experience in finance and business ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks